See the DrugPatentWatch profile for Kovaltry
What is Kovaltry, and how is it dosed?
Kovaltry (antihemophilic factor [recombinant] [rFVIII]) dosing depends on (1) whether you are treating bleeding (on-demand) or preventing bleeds (prophylaxis), and (2) your factor level targets and how long you want to maintain them. [1]
How is Kovaltry dosed for bleeding episodes?
For bleeding, the key dosing concept is to give Kovaltry to raise and maintain your factor VIII level enough to stop the bleed. The exact dose and how often you repeat it are based on:
- the severity and location of the bleed
- your initial factor VIII level response
- the goal factor level
These instructions are individualized and follow the dosing guidance in the prescribing information. [1]
How is Kovaltry dosed for routine prophylaxis?
For prophylaxis, Kovaltry is given on a scheduled regimen to reduce the frequency of bleeding. The regimen is based on:
- your target trough factor VIII level (a lower-end level you aim to keep above a threshold)
- your bleeding history and personal response to treatment
Your prescriber sets the starting dose and interval using the dosing table in the product labeling. [1]
What factors change the dose or interval?
Dosing can change if any of the following apply:
- the type and severity of bleeding or surgery
- the target factor VIII level your clinician is aiming for
- your measured response to rFVIII (factor levels can vary between patients)
- treatment goals (on-demand versus prophylaxis)
The prescribing information provides dosing by clinical scenario and target factor level. [1]
How is Kovaltry administered?
Kovaltry is given as an intravenous injection (into a vein). Your clinician will instruct you on reconstitution and injection technique, including how often you should infuse based on the regimen you are on. [1]
What should patients ask their clinician before starting or changing Kovaltry?
Patients typically confirm:
- the exact dose (amount) and dosing interval for their use case (bleeding vs prophylaxis)
- the factor VIII level targets their plan uses
- whether they need any lab monitoring to guide dose adjustments
- how dosing should be adjusted around dental work, injuries, or planned procedures
These points align with how Kovaltry dosing is set in the labeling. [1]
Sources
- https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125397